Literature DB >> 16003275

Peculiar aspects of cardiogenic embolism in patients with Chagas' cardiomyopathy: a transthoracic and transesophageal echocardiographic study.

Maria do Carmo P Nunes1, Márcia M Barbosa, Manoel Otávio C Rocha.   

Abstract

OBJECTIVES: We sought to detect cardiac thrombi by transthoracic and transesophageal echocardiography in patients with Chagas' cardiomyopathy and to determine the relationship of these thrombi with left ventricular systolic function and with the presence of stroke.
BACKGROUND: Thromboembolic events are a serious complication of Chagas' cardiomyopathy. Because most data come from autopsy studies, the prevalence of cardiac thrombi for patients who are clinically stable is unknown.
METHODS: A total of 75 patients (52 men; mean age 48 +/- 13 years) with Chagas' cardiomyopathy were prospectively studied by transthoracic and transesophageal echocardiography and followed for 24 +/- 10 months.
RESULTS: In all, 14 patients (19%) had a history of stroke at the time of enrollment and two had this complication at follow-up. Most patients (88%) were in New York Heart Association (NYHA) functional classes I and II and 9 (12%) were in classes III and IV. Mean ejection fraction was 40 +/- 13%. A total of 17 patients (23%) had left ventricular thrombus on transthoracic echocardiography and this finding was associated with a history of stroke ( P = .01). Apical aneurysm occurred in 35 patients (47%) and it was associated both with thrombus and stroke ( P = .04). Strokes were more frequent ( P = .04) among patients with mild systolic dysfunction (57% of patients with strokes were in NYHA I). Four patients (5%) had thrombi at the left atrial appendage, and one (1%) at the right atrial appendage. A total of 13 patients (17%) died at follow-up.
CONCLUSIONS: Stroke was frequent in Chagas' cardiomyopathy and associated with mild systolic dysfunction and with intracardiac thrombi. These occurred mainly in the typical apical aneurysm of Chagas' disease.

Entities:  

Mesh:

Year:  2005        PMID: 16003275     DOI: 10.1016/j.echo.2005.01.026

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  10 in total

1.  Inhibition of NFE2L2-Antioxidant Response Element Pathway by Mitochondrial Reactive Oxygen Species Contributes to Development of Cardiomyopathy and Left Ventricular Dysfunction in Chagas Disease.

Authors:  Jake Jianjun Wen; Craig Porter; Nisha Jain Garg
Journal:  Antioxid Redox Signal       Date:  2017-07-13       Impact factor: 8.401

2.  Stroke in Chagas disease: from pathophysiology to clinical practice.

Authors:  Thaís Aparecida Reis Lage; Julia Teixeira Tupinambás; Lucas Bretas de Pádua; Matheus de Oliveira Ferreira; Amanda Cambraia Ferreira; Antonio Lucio Teixeira; Maria Carmo Pereira Nunes
Journal:  Rev Soc Bras Med Trop       Date:  2022-06-06       Impact factor: 2.141

Review 3.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

Review 4.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

Review 5.  Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death.

Authors:  Antonia Pino-Marín; Germán José Medina-Rincón; Sebastian Gallo-Bernal; Alejandro Duran-Crane; Álvaro Ignacio Arango Duque; María Juliana Rodríguez; Ramón Medina-Mur; Frida T Manrique; Julian F Forero; Hector M Medina
Journal:  Pathogens       Date:  2021-04-22

6.  Multiple Strokes in a Latin American Patient.

Authors:  Ramez Halaseh; Malik Shehadeh; Rachel Marcus
Journal:  Case Rep Neurol       Date:  2021-07-08

7.  Histopathological Correlates of Global and Segmental Left Ventricular Systolic Dysfunction in Experimental Chronic Chagas Cardiomyopathy.

Authors:  Luciano Fonseca Lemos de Oliveira; Minna Moreira Dias Romano; Eduardo Elias Vieira de Carvalho; Jorge Mejia Cabeza; Hélio Cesar Salgado; Rubens Fazan Júnior; Renata Sesti Costa; João Santana da Silva; Maria de Lourdes Higuchi; Benedito Carlos Maciel; Edécio Cunha-Neto; José Antônio Marin-Neto; Marcus Vinícius Simões
Journal:  J Am Heart Assoc       Date:  2016-01-21       Impact factor: 5.501

8.  Cognitive dysfunction in chronic Chagas disease cardiomyopathy.

Authors:  Jesângeli Sousa Dias; Amanda M Lacerda; Rodrigo M Vieira-de-Melo; Leila C Viana; Pedro A P Jesus; Francisco J F B Reis; Ricardo Nitrini; Helenice Charchat-Fichman; Antônio A Lopes; Jamary Oliveira-Filho
Journal:  Dement Neuropsychol       Date:  2009 Jan-Mar

Review 9.  Stroke and brain atrophy in chronic Chagas disease patients: A new theory proposition.

Authors:  Jamary Oliveira-Filho
Journal:  Dement Neuropsychol       Date:  2009 Jan-Mar

10.  Clinical assessment, neuroimaging and immunomarkers in Chagas disease study (CLINICS): Rationale, study design and preliminary findings.

Authors:  Jamary Oliveira-Filho; Jesângeli de S Dias; Pedro A P Jesus; Nestor J S B Neto; Roque Aras; Francisco J F B Reis; Karen L Furie
Journal:  Dement Neuropsychol       Date:  2012 Jul-Sep
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.